Abstract
IntroductionAn effective rifampicin-resistant tuberculosis (RR-TB) treatment regimen should include prevention of resistance amplification. While bedaquiline (BDQ) has been recommended in all-oral RR-TB treatment regimen since 2019, resistance is rising at...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have